Himanshu Gupta Assistant Professor, Department of Emergency Medicine, Jaipur National University Institute for Medical Sciences and Research Centre, Jaipur 302017, Rajasthan, India
Address for correspondence: Himanshu Gupta, Assistant Professor, Department of Emergency Medicine, Jaipur National University Institute for Medical Sciences and Research Centre, Jaipur 302017, Rajasthan, India E-mail: dr.himanshu1182@gmail.com
This license enables reusers to distribute, remix, adapt,
and build upon the material in any medium or format for noncommercial purposes
only, and only so long as attribution is given to the creator.
Gupta H. Acute pancreatitis: it’s not always “on the rocks”. Ind J Emerg Med. 2024;10(3):147-51.
Timeline
Received : May 30, 2024
Accepted : August 05, 2024
Published : September 10, 2024
Abstract
Acute pancreatitis is one among the common causes of pain abdomen presenting to emergency department. Some of the most common causes of acute pancreatitis include gallstones, alcohol use, hypertriglyceridemia and Drugs. Over 500 drugs are implicated as a causative agents and account for less than 2% of cases. Sodium valproate, one of the commonly prescribed anti-epileptic drug is known to cause acute pancreatitis.
Here, we are presenting a case of a 26-years-old male who is a known case of juvenile myoclonic epilepsy on sodium valproate who presented with acute pancreatitis.
Our reasons for highlighting this case are:
To illustrate a patient with juvenile myoclonic epilepsy on sodium valproate developing acute pancreatitis with other adverse effects like gum hypertrophy, vitamin B12 and folate deficiency.
2. Walkowska J., Zielinska N., Karauda P., Tubbs R.S., Kurtys K., Olewnik L. The pancreas and known factors of acute pancreatitis. J Clin. Med. 2022;11:5565. doi: 10.3390/jcm11195565.
3. Barakat M.T., Abu-El-Haija M., Husain S.Z. Clinical insights into drug-associated pancreatic injury.Curr. Opin. Gastroenterol.2022;38:482–486. doi: 10.1097/MOG.0000000000000865.
4. Peterson G.M., Naunton M. Valproate: A simple chemical with so much to offer. J. Clin. Pharm. Ther. 2005;30:417–421. doi: 10.1111/j.1365-2710.2005.00671.x.
5. Wartman C., VandenBerg A. Valproate: Not all boxed warnings are created equal. Ann. Pharmacother. 2022;56:1349–1355. doi: 10.1177/10600280221085991.
6. Genton P, Gelisse P. Vaproic acid. Adverse effects. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Antipepileptic drugs. 5th ed. Lippincott William &Wilkins, Philadelphia, 2002;838–851.
8. Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid overdose: a systematic review of published cases. Ann Pharmacother. 2010;44(7–8):1287–93.
9. Davis RB, Sunder TR, Barakat HA, May R. Valproate Alters the Membrane Phospholipids of Erythrocytes. Epilepsia. 1991;32;11-2.
10. Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. Periodontol. 2000;1999(21):176.
11. Yazdani K, Lippmann M, Gala I. Fatal pancreatitis associated with valproic acid, review of the literature. Medicine. 2002;81(4):305–10.
13. Gerstner T, Büsing D, Bell N, Longin E, Kasper JM, Klostermann W, et al. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol. 2007;42:39–48.
Data Sharing Statement
There are no additional data available.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Acknowledgements
Information not provided.
Conflicts of Interest
The authors report no conflicts of interest in this work.
About this article
Cite this article
Gupta H. Acute pancreatitis: it’s not always “on the rocks”. Ind J Emerg Med. 2024;10(3):147-51.
This license enables reusers to distribute, remix, adapt,
and build upon the material in any medium or format for noncommercial purposes
only, and only so long as attribution is given to the creator.
This license enables reusers to distribute, remix, adapt,
and build upon the material in any medium or format for noncommercial purposes
only, and only so long as attribution is given to the creator.
Contrast enhanced CT scan of abdomen showing diffuse bulky pancreas. Head, body and tail measures 33 mm, 32 mm and 35 mm respectively. Homogenous contrast enhancement is noted.